GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (OTCPK:XTXXF) » Definitions » Research & Development

XTXXF (Adastra Holdings) Research & Development : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Adastra Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Adastra Holdings's Research & Development for the three months ended in Sep. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Adastra Holdings Research & Development Historical Data

The historical data trend for Adastra Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings Research & Development Chart

Adastra Holdings Annual Data
Trend Apr19 Dec20 Dec21 Dec22 Dec23
Research & Development
- 0.14 0.07 - -

Adastra Holdings Quarterly Data
Oct18 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Adastra Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adastra Holdings  (OTCPK:XTXXF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Adastra Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Adastra Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (OTCPK:XTXXF) » Definitions » Research & Development
Comparable Companies
TSX:VPH XCNQ:CANN TSX:XLY TSX:CTX TSXV:MPH XCNQ:BAMM NEOE:TILT XCNQ:RVV XCNQ:MVMD TSX:WLLW ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
D2E0:Germany XTRX:Canada
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Website
https://www.adastraholdings.ca
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.